{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:22:39Z","timestamp":1789014159921,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.yrtph.2015.10.021","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T13:07:18Z","timestamp":1446210438000},"page":"737-746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Target organ profiles in toxicity studies supporting human dosing: Does severity progress with longer duration of exposure?"],"prefix":"10.1016","volume":"73","author":[{"given":"Ruth","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0245-6557","authenticated-orcid":false,"given":"Richard","family":"Callander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Boobis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2015.10.021_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.yrtph.2008.04.006","article-title":"Safety evaluation to support first-in-man investigations II: toxicology studies","volume":"51","author":"Baldrick","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.yrtph.2015.10.021_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0168-8278(97)80494-1","article-title":"Hepatotoxicity in drug development: detection, significance and solutions","volume":"26","author":"Ballet","year":"1997","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.yrtph.2015.10.021_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.toxlet.2011.05.1030","article-title":"Evaluation of time extrapolation factors based on the database RepDose","volume":"205","author":"Batke","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2015.10.021_bib4","series-title":"Guidance on Information Requirements and Chemical Safety Assessment. Chapter R.7a: Endpoint Specific Guidance","author":"ECHA","year":"2014"},{"key":"10.1016\/j.yrtph.2015.10.021_bib5","series-title":"Data Requirements for Active Substances. Commission Regulation (EU) No 283\/2013 of 1 March 2013","author":"EU","year":"2013"},{"key":"10.1016\/j.yrtph.2015.10.021_bib6","series-title":"Data Requirements for Plant Protection Products. Commission Regulation (EU) No 284\/2013 of 1 March 2013","author":"EU","year":"2013"},{"key":"10.1016\/j.yrtph.2015.10.021_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrd1329","article-title":"First dose of potential new medicines to humans: how animals help","volume":"3","author":"Greaves","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.yrtph.2015.10.021_bib8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0378-4274(81)90125-9","article-title":"Target organ toxicity","volume":"8","author":"Heywood","year":"1981","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2015.10.021_bib9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.yrtph.2013.02.002","article-title":"Target organ toxicities in studies conducted to support first time in man dosing: an analysis across species and therapy areas","volume":"65","author":"Horner","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.10.021_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.yrtph.2014.07.008","article-title":"Target organ profiles in toxicity studies supporting human dosing: an assessment of recovery and chronic dosing","volume":"70","author":"Horner","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.10.021_bib11","series-title":"Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals","author":"ICH Guideline M3(R2)","year":"2009"},{"key":"10.1016\/j.yrtph.2015.10.021_bib12","series-title":"Repeated Dose 28-day Oral Toxicity Study in Rodents","author":"OECD Guideline 407","year":"2008"},{"key":"10.1016\/j.yrtph.2015.10.021_bib13","series-title":"Repeated Dose 90-day Oral Toxicity Study in Rodents","author":"OECD Guideline 408","year":"1998"},{"key":"10.1016\/j.yrtph.2015.10.021_bib14","series-title":"Repeated Dose 90-day Oral Toxicity Study in Non-rodents","author":"OECD Guideline 409","year":"1998"},{"key":"10.1016\/j.yrtph.2015.10.021_bib15","series-title":"Chronic Toxicity Studies","author":"OECD Guideline 452","year":"2009"},{"key":"10.1016\/j.yrtph.2015.10.021_bib16","series-title":"Combined Chronic Toxicity\/Carcinogenicity Studies","author":"OECD Guideline 453","year":"2009"},{"key":"10.1016\/j.yrtph.2015.10.021_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Reg. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.10.021_bib18","series-title":"World Health Organisation International Programme on Chemical Safety Environmental Health Criteria 240: Principles and Methods for the Risk Assessment of Chemicals in Food","author":"WHO","year":"2009"},{"key":"10.1016\/j.yrtph.2015.10.021_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.yrtph.2011.08.004","article-title":"Study parameters influencing NOAEL and LOAEL in toxicity feeding studies for pesticides: exposure duration versus dose decrement, dose spacing, group size and chemical class","volume":"61","author":"Zarn","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.10.021_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yrtph.2013.07.012","article-title":"Characterization of the dose decrement in regulatory rat pesticide toxicity feeding studies","volume":"67","author":"Zarn","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.10.021_bib21","first-page":"72","article-title":"The significance of the subchronic toxicity in the dietary risk assessment of pesticides. Regul. Toxicol","volume":"58","author":"Zarn","year":"2010","journal-title":"Pharmacol"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230015301057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230015301057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T01:52:46Z","timestamp":1537235566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230015301057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0273230015301057"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2015.10.021","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Target organ profiles in toxicity studies supporting human dosing: Does severity progress with longer duration of exposure?","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2015.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}